We investigated whether atrial natriuretic peptide (ANP) given just prior to reperfusion
reduces infarction in rabbit hearts and whether protection is related to activation of protein …

BACKGROUND: Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate
cyclase, has been found to protect against reoxygenation-induced hypercontracture in …

The aim of the present study was to examine the effects of atrial natriuretic peptide (ANP) on
the responses to coronary artery occlusion. In chloralose-urethane anaesthetised mongrel …

Objectives: The aim of this investigation was to test whether the administration of atrial
natriuretic peptide (ANP) has cardioprotective effects against ischaemic and reperfusion …

Atrial natriuretic peptide (ANP) is a member of the natriuretic peptide family that exerts
various biological effects via acting on the receptor-guanylyl cyclase system, increasing the …

Carperitide, a synthetic alpha-human atrial natriuretic peptide (ANP) is a newly developed
drug for the treatment of heart failure. However, effects of carperitide on susceptibility to …

Natriuretic peptides are regulatory autacoids in the mammalian myocardium whose
functions, mediated via particulate guanylyl cyclase/cGMP, may include cytoprotection …

To evaluate the effects of synthetic human atrial natriuretic peptide (hANP) on myocardial
reperfusion injury and left ventricular remodeling, 19 patients within 12h of a first attack of …

B-type natriuretic peptide (BNP) has been reported to be released from the myocardium
during ischemia. We hypothesized that BNP mediates cardioprotection during ischemia …

We measured atrial natriuretic peptide (ANP) plasma levels in rats with experimental heart
failure caused by left coronary artery ligation. ANP levels were clearly higher in infarcted rats …